Shengdong Huang
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 5
- Oncology top 10%
- Cancer Cells and Metastasis 4
- Clinical Biochemistry top 5%
- Immunology top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 5
- Angiogenesis and VEGF in Cancer 5
-
- Electrospun Nanofibers in Biomedical Applications 5
-
- Cardiac Valve Diseases and Treatments 4
-
- Mesenchymal stem cell research 4
-
- Tissue Engineering and Regenerative Medicine 3
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Shengdong Huang
60 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 378
- Oncology 377
- Clinical Biochemistry 89
- Immunology 248
- Molecular Biology 785
Countries citing papers authored by Shengdong Huang
This map shows the geographic impact of Shengdong Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengdong Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengdong Huang more than expected).
Fields of papers citing papers by Shengdong Huang
This network shows the impact of papers produced by Shengdong Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengdong Huang. The network helps show where Shengdong Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengdong Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2016 | 32 | |
| 4 | 2016 | 16 | |
| 5 | 2014 | 26 | |
| 6 | 2014 | 35 | |
| 7 | 2013 | 24 | |
| 8 | 2013 | 16 | |
| 9 | 2011 | 85 | |
| 10 | 2010 | 57 | |
| 11 | 2010 | 203 | |
| 12 | 2010 | 74 | |
| 13 | 2009 | 30 | |
| 14 | 2008 | 62 | |
| 15 | Recombinant adeno-associated virus mediated RNA interference of angiogenin inhibits growth of human lung squamous cancer cells | 2007 | 1 |
| 16 | 2007 | 16 | |
| 17 | 2007 | 14 | |
| 18 | 2007 | 24 | |
| 19 | 2007 | 8 | |
| 20 | 2005 | 2 |
About Shengdong Huang
Shengdong Huang is a scholar working on Cancer Research, Developmental Neuroscience and Molecular Biology, having authored 62 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cardiac Valve Diseases and Treatments (4 papers), Cancer Cells and Metastasis (4 papers), Mesenchymal stem cell research (4 papers) and Tissue Engineering and Regenerative Medicine (3 papers). The work is most often cited by research in Cancer Research (378 citations), Oncology (377 citations) and Clinical Biochemistry (89 citations). Shengdong Huang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dejun Gong, Yang Yuan, Yan Zhang, Qian Shen, Yanghua Qin, Zhiyun Xu, Xiaohong Liu, Zhiyong Zeng, Liang-jian Zou and Zhiyun Xu. Their work appears in journals such as PLoS ONE, Molecular and Cellular Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.